RBC Capital Defends Johnson & Johnson (JNJ) Amid Talc Concerns

January 22, 2026 8:39 AM UTC Send to a Friend
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $240.00 price target on Johnson & Johnson (NYSE: JNJ).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login